ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 033,13
1,20%
Dow Jones
38 743,21
0,08%
DAX
18 613,90
1,07%
Brent Oil
77,885
1,01%
Bitcoin
70 792,17
0,24%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Ayala Pharmaceuticals Inc (PK) (ADXS)

  7. Ayala Pharmaceuticals Inc (PK) (ADXS) Actualités

ADXS

Ayala Pharmaceuticals (PK) (ADXS)

Ayala Pharmaceuticals Inc (PK)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:ADXS
DateHeureSourceTitreSymboleSociété
06/03/202413h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202422h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202414h16Edgar (US Regulatory)Form DEFM14C - Definitive information statement relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/02/202423h22Edgar (US Regulatory)Form PREM14C - Preliminary information statements relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
14/02/202422h26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202417h58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/01/202422h18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/11/202315h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/11/202322h04Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/11/202322h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202316h46Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
02/11/202321h05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
29/09/202312h13Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
11/09/202318h38Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/05/202319h11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/05/202322h11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
07/04/202323h21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
06/04/202323h24Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
10/02/202312h08Edgar (US Regulatory)Annual Report (10-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/02/202323h20Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
30/01/202322h52Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
30/01/202312h38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
24/01/202300h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/01/202322h06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/12/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/12/202212h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/12/202222h53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/06/202212h02Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/05/202222h55Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
28/03/202214h57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:ADXS

Dernières Valeurs Consultées

HUOB
SWEATUSDT
SWEAT
BIT
P20L56
NLBNPIT20L56 20991231 0....
EU
IN17G
IN17G
NYSE
SB-B.CL
BIT
F17973
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés